UK Technology Strategy Board to invest £15 million in new healthcare technologies

January 9, 2008, Swindon, UK--The Technology Strategy Board (TSB) will invest £15 million (US$29 million) to support research and development in new technologies for healthcare, including lasers, optics, and imaging.

The TSB's Technologies for Health competition--part of the TSB's Autumn 2007 call for proposals in a number of innovation and technology areas--is designed to help stimulate innovation that will improve healthcare by bringing medical diagnosis (self or professional), condition monitoring and care and analytical capabilities closer to the patient community.

The investment will fund highly innovative industry-led collaborative research and development projects that will develop technologies to encourage localization of healthcare services. Such projects might include:

* Devices for minimally invasive intervention, treatment, monitoring and therapy.
* Devices for in- or on- the body applications.
* Low-cost tools for self-diagnosis.
* Devices and sensors for early and rapid detection of disease.
* Scaled-down devices for point-of-care diagnosis and sample analysis.
* Devices for point-of-use drug synthesis or drug delivery.
* Developments for animal health and detection of diseases in animals.
* Imaging technologies to identify biomarkers which predict drug efficacy.

The TSB's investment will provide partial funding for winning projects in such areas, and which involve businesses working collaboratively with other businesses and/or with research organizations and academic institutions. One or a combination of technologies can be used, such as:

* Photonics: including lasers, optical fibres, fluorescence and photodynamic techniques, spectroscopy and imaging.
* Electronics: including sensors, chemical or biological recognition transducers and data capture and transmission.
* Microfluidics, microsystems and system-on-chip architectures.
* Nanomaterials and nanodevices.
* Telecommunications technologies.
* Fluid and tissue manipulation, biofabrication, microanalysers, and microarrays.

The projects, which can last for 2 to 3 years, can range from small, highly focussed basic research projects aimed at establishing technical feasibility, to applied research and experimental development projects.

"Bringing healthcare closer to the community, away from hospitals to GPs' surgeries and even into the home, can be cost effective as well as offer operational improvements," said TSB Chief Executive Iain Gray. "Developing technologies to enable this to happen is a major challenge, which we believe can be met by UK companies."

Applicants must register their intention to apply for funding, and submit an outline of their proposal, by 22 February 2008 and the final closing date for applications is 27 March 2008. Further information is available at Technology Strategy Board.